Linda Garland, MD

-
Professor, Medicine, Clinical Scholar
Biography
Undergraduate Education
University of Texas at Austin Austin, Texas, Bachelor of Arts with High Honors, 1983, Special Honors in Psychology
1979 -1983
Medical Education
University of Texas Health Science Center at San Antonio, San Antonio, Texas
8/1984 -5/1988
Surgery Internship, Department of Surgery University of Texas Health Science Center at San Antonio, San Antonio, Texas
7/1988 -6/1989
Internal Medicine Internship and Residency, Department of Internal Medicine, University of South Florida College of Medicine, Tampa, Florida
7/1990 - 6/1993
Medical Oncology and Hematology Fellowship, Division of Medical Oncology and Hematology, H. Lee Moffitt Cancer Center and Research Institute, University of South Florida College of Medicine, Tampa, Florida
7/1993 – 6/1996
Employment
7/1996 – 1/2000
Assistant Professor of Medicine, Thoracic Oncology Program, H. Lee Moffitt Cancer Center, University of South Florida College of Medicine, Tampa, Florida
2/2000 – 6/2007
Assistant Professor of Medicine, Clinical Scholar Track,
Director, Clinical Research in Thoracic Oncology, University of Arizona Cancer Center, Division of Hematology/Oncology, Department of Medicine
7/2007 – 5/2018
Associate Professor of Medicine, Clinical Scholar Track
Director, Clinical Research in Thoracic Oncology, University of Arizona Cancer Center, Division of Hematology/Oncology, Department of Medicine, University of Arizona Health Sciences Center
6/2018 – Present
Professor of Medicine, Clinical Scholar Track
Director, Clinical Research in Thoracic Oncology
University of Arizona Cancer Center, Division of Hematology/Oncology, Department of Medicine , University of Arizona Health Sciences Center
Cancer Focus
-Lung cancer chemoprevention with repurposed drugs including arachidonic acid inhibitors and immune modulators, and incorporating novel non-invasive biomarkers of gene expression.
-Lung cancer survivorship studies including lung cancer stigma, lung cancer outcomes by race/ethnicity, coping responses in the face of the COVID pandemic, tobacco cessation.
-Translation of a novel methylation signature discovered at the UACC for improving lung cancer diagnosis and treatment response.
Selected Publications
Vrba, L., M. M. Oshiro, S. S. Kim, L. L. Garland, C. Placencia, D. Mahadevan, M. A. Nelson, and B. W. Futscher, "DNA methylation biomarkers discovered detect cancer in liquid biopsies from non-small cell lung cancer patients.", Epigenetics, vol. 15, issue 4, pp. 419-430, 2020 04. PMCID: PMC7153541 PMID: 31775567
Garland, L. L., J. Guillen-Rodriguez, C-H. Hsu, M. Yozwiak, H. Helen Zhang, D. S. Alberts, L. E. Davis, E. Szabo, C. Merenstein, J. Lel, et al., "Effect of Intermittent Versus Continuous Low-Dose Aspirin on Nasal Epithelium Gene Expression in Current Smokers: A Randomized, Double-Blinded Trial.", Cancer Prev Res (Phila), vol. 12, issue 11, pp. 809-820, 2019 11. PMCID: PMC7485120 PMID: 31451521
Eshghi, N., L. L. Garland, G. Choudhary, C. C. Hsu, A. Eshghi, J. Han, R. J. Hamilton, E. Krupinski, and P. H. Kuo, "Regional Changes in Brain F-FDG Uptake After Prophylactic Cranial Irradiation and Chemotherapy in Small Cell Lung Cancer May Reflect Functional Changes.", J Nucl Med Technol, vol. 46, issue 4, pp. 355-358, 2018 Dec. PMID: 30076247
Hakim, I. A., R. Harris, L. Garland, C. A. Cordova, D. M. Mikhael, and H-H. Sherry Chow, "Gender difference in systemic oxidative stress and antioxidant capacity in current and former heavy smokers.", Cancer Epidemiol Biomarkers Prev, vol. 21, issue 12, pp. 2193-200, 2012 Dec. PMID: 23033455
Chow, H-H. Sherry, L. L. Garland, C-H. Hsu, D. R. Vining, W. M. Chew, J. A. Miller, M. Perloff, J. A. Crowell, and D. S. Alberts, "Resveratrol modulates drug- and carcinogen-metabolizing enzymes in a healthy volunteer study.", Cancer Prev Res (Phila), vol. 3, issue 9, pp. 1168-75, 2010 Sep. PMCID: PMC2933312 PMID: 20716633